Jacob Gottlieb Begins Altium Capital Investment Firm

Jason Gottlieb recently embarked upon a new venture known as Altium Capital. This healthcare fund is headquartered in New York City, New York. The fund invests in companies that provide medical treatments. The fund’s initial investment venture was over a 5% stake in the Oramed Pharmaceuticals oral diabetes treatment for patients who typically are provided injections. Additionally, Altium Capital has invested in the companies Dublin, Ireland based company Amarin and Oragenics, which is a company founded by two medical doctors who strive to excel in the novel antibiotic treatment to combat infectious diseases.

Gottlieb held multiple prestigious positions in his career prior to his current venture. He was one of the founders of Balyasny Asset Management, L.P. Additionally, he worked as a portfolio manager at Merlin, founded Visium Asset Management, and served as a Buy-side Analyst. Gottlieb completed his medical internship in internal medicine.

The education he received prepared Jason Gottlieb for his career path. He earned a Bachelor of Arts degree in Economics from Brown University. He received an MD from New York University Medical School. After his medical internship, Gottlieb decided to leave medicine and work in the financial industry and worked to obtain the credentials necessary for his new career. Gottlieb became a Chartered Financial Analyst in 2001 and later received a P.R.M. designation.

In addition to his work in the investment industry with Altium Capital, Jason Gottlieb serves the state of New York as a volunteer and philanthropist. Gottlieb attributes his success to the education he received. Due to his love for education, Gottlieb supports education charities which offer individuals a foundation for future success on both personal and professional levels. Jason Gottlieb has participated in multimillion dollar fundraisers for charities such as Robin Hood Foundation, East Harlem Tutorial Program, and New Yorkers for Children.

Find out more about Jacob Gottlieb: https://www.cnbc.com/jacob-gottlieb–cnbc/